Tony Michael Argenbright

Array ( [id] => 102667 [patent_doc_number] => 07728127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/895534 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17115 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728127.pdf [firstpage_image] =>[orig_patent_app_number] => 11895534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4798035 [patent_doc_number] => 20080009621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Control of Cyanate in Aqueous Urea Solutions by non-1,2-Ethylene Diamine like Compounds for the Protection of Protein/Peptide Carbamylation' [patent_app_type] => utility [patent_app_number] => 11/844600 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5433 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009621.pdf [firstpage_image] =>[orig_patent_app_number] => 11844600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177913 [patent_doc_number] => 07655621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/895555 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17108 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655621.pdf [firstpage_image] =>[orig_patent_app_number] => 11895555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652355 [patent_doc_number] => 20080039611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/895553 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17066 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039611.pdf [firstpage_image] =>[orig_patent_app_number] => 11895553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813834 [patent_doc_number] => 20080194465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/895533 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17057 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194465.pdf [firstpage_image] =>[orig_patent_app_number] => 11895533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813833 [patent_doc_number] => 20080194464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/895531 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17063 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194464.pdf [firstpage_image] =>[orig_patent_app_number] => 11895531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682842 [patent_doc_number] => 20080249068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Method of Extending the Dose Range of Vitamin D Compounds' [patent_app_type] => utility [patent_app_number] => 11/842752 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7476 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249068.pdf [firstpage_image] =>[orig_patent_app_number] => 11842752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786462 [patent_doc_number] => 20080139791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Pharmaceutically acceptable Fn3 Polypeptides for human treatments' [patent_app_type] => utility [patent_app_number] => 11/894732 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20271 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139791.pdf [firstpage_image] =>[orig_patent_app_number] => 11894732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6492884 [patent_doc_number] => 20100093643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CARDIOPROTECTIVE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/310193 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8263 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093643.pdf [firstpage_image] =>[orig_patent_app_number] => 12310193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758857 [patent_doc_number] => 20080311083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods of Modulating Beta Cell Function' [patent_app_type] => utility [patent_app_number] => 11/837183 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22041 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311083.pdf [firstpage_image] =>[orig_patent_app_number] => 11837183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704128 [patent_doc_number] => 20080063651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Fibronectin derivative Fc fusions' [patent_app_type] => utility [patent_app_number] => 11/890554 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20237 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20080063651.pdf [firstpage_image] =>[orig_patent_app_number] => 11890554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965978 [patent_doc_number] => 20080108798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Selection of fibronectin scaffolds using nucleic acid-protein fusions' [patent_app_type] => utility [patent_app_number] => 11/890627 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 40932 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108798.pdf [firstpage_image] =>[orig_patent_app_number] => 11890627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803750 [patent_doc_number] => 20080015339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'High affinity fibronectin derivatives' [patent_app_type] => utility [patent_app_number] => 11/890645 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20238 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015339.pdf [firstpage_image] =>[orig_patent_app_number] => 11890645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765575 [patent_doc_number] => 20080176787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Parathyroid hormone analogues and methods of use' [patent_app_type] => utility [patent_app_number] => 11/890248 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 39106 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176787.pdf [firstpage_image] =>[orig_patent_app_number] => 11890248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355171 [patent_doc_number] => 20100022441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'N-TERMINAL POLYSIALYLATION' [patent_app_type] => utility [patent_app_number] => 12/375010 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9866 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022441.pdf [firstpage_image] =>[orig_patent_app_number] => 12375010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664133 [patent_doc_number] => 20080255040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES' [patent_app_type] => utility [patent_app_number] => 11/781888 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 77697 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255040.pdf [firstpage_image] =>[orig_patent_app_number] => 11781888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840332 [patent_doc_number] => 20080280818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'GLYCOSYLATION OF PEPTIDES VIA O-LINKED GLYCOSYLATION SEQUENCES' [patent_app_type] => utility [patent_app_number] => 11/781885 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 77832 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280818.pdf [firstpage_image] =>[orig_patent_app_number] => 11781885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477274 [patent_doc_number] => 07906478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Personal-care articles having self-assembling peptides' [patent_app_type] => utility [patent_app_number] => 11/880353 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6441 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906478.pdf [firstpage_image] =>[orig_patent_app_number] => 11880353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6347895 [patent_doc_number] => 20100021391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'NOVEL NANOPARTICLES FOR BIOFILM TARGETING' [patent_app_type] => utility [patent_app_number] => 11/777944 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16122 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021391.pdf [firstpage_image] =>[orig_patent_app_number] => 11777944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802677 [patent_doc_number] => 20080014265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'PHARMACEUTICAL COMPOSITION AS SOLID DOSAGE FORM AND METHOD FOR MANUFACTURING THEREOF' [patent_app_type] => utility [patent_app_number] => 11/775695 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3025 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014265.pdf [firstpage_image] =>[orig_patent_app_number] => 11775695 [rel_patent_id] =>[rel_patent_doc_number] =>)